Bruton’s Tyrosine Kinase Inhibition in Multiple Sclerosis

PURPOSE OF REVIEW: Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) with a chronic and often progressive disease course. The current disease-modifying treatments (DMTs) limit disease progression primarily by dampening immune cell activity in the peripheral blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Raphael, Oh, Jiwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Demyelinating Disorders (J. Bernard and M. Cameron, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607648/
https://www.ncbi.nlm.nih.gov/pubmed/36301434
http://dx.doi.org/10.1007/s11910-022-01229-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607648/
https://www.ncbi.nlm.nih.gov/pubmed/36301434
http://dx.doi.org/10.1007/s11910-022-01229-z

Ejemplares similares